BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1696 related articles for article (PubMed ID: 26666243)

  • 21. Comparison and evaluation of two exome capture kits and sequencing platforms for variant calling.
    Zhang G; Wang J; Yang J; Li W; Deng Y; Li J; Huang J; Hu S; Zhang B
    BMC Genomics; 2015 Aug; 16(1):581. PubMed ID: 26242175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of next generation sequencing to molecular diagnosis of inherited diseases.
    Zhang W; Cui H; Wong LJ
    Top Curr Chem; 2014; 336():19-45. PubMed ID: 22576358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dependable and efficient clinical utility of target capture-based deep sequencing in molecular diagnosis of retinitis pigmentosa.
    Wang J; Zhang VW; Feng Y; Tian X; Li FY; Truong C; Wang G; Chiang PW; Lewis RA; Wong LJ
    Invest Ophthalmol Vis Sci; 2014 Aug; 55(10):6213-23. PubMed ID: 25097241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of variations and identifying genomic breakpoints for large deletions in the LDLR by Ion Torrent semiconductor sequencing.
    Faiz F; Allcock RJ; Hooper AJ; van Bockxmeer FM
    Atherosclerosis; 2013 Oct; 230(2):249-55. PubMed ID: 24075752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and Validation of a Next-Generation Sequencing Assay for BRCA1 and BRCA2 Variants for the Clinical Laboratory.
    Strom CM; Rivera S; Elzinga C; Angeloni T; Rosenthal SH; Goos-Root D; Siaw M; Platt J; Braastadt C; Cheng L; Ross D; Sun W
    PLoS One; 2015; 10(8):e0136419. PubMed ID: 26295337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sequencing-based diagnostics for pediatric genetic diseases: progress and potential.
    Abou Tayoun AN; Krock B; Spinner NB
    Expert Rev Mol Diagn; 2016 Sep; 16(9):987-99. PubMed ID: 27388938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dealing with the incidental finding of secondary variants by the example of SRNS patients undergoing targeted next-generation sequencing.
    Weber S; Büscher AK; Hagmann H; Liebau MC; Heberle C; Ludwig M; Rath S; Alberer M; Beissert A; Zenker M; Hoyer PF; Konrad M; Klein HG; Hoefele J
    Pediatr Nephrol; 2016 Jan; 31(1):73-81. PubMed ID: 26248470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Performance characteristics of the AmpliSeq Cancer Hotspot panel v2 in combination with the Ion Torrent Next Generation Sequencing Personal Genome Machine.
    Butler KS; Young MY; Li Z; Elespuru RK; Wood SC
    Regul Toxicol Pharmacol; 2016 Feb; 74():178-86. PubMed ID: 26387931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Replicate exome-sequencing in a multiple-generation family: improved interpretation of next-generation sequencing data.
    Cherukuri PF; Maduro V; Fuentes-Fajardo KV; Lam K; ; Adams DR; Tifft CJ; Mullikin JC; Gahl WA; Boerkoel CF
    BMC Genomics; 2015 Nov; 16():998. PubMed ID: 26602380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted Next-Generation Sequencing for Clinical Diagnosis of 561 Mendelian Diseases.
    Liu Y; Wei X; Kong X; Guo X; Sun Y; Man J; Du L; Zhu H; Qu Z; Tian P; Mao B; Yang Y
    PLoS One; 2015; 10(8):e0133636. PubMed ID: 26274329
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of Ion Personal Genome Machine Platforms for the Detection of Variants in
    Hwang SM; Lee KC; Lee MS; Park KU
    Cancer Res Treat; 2018 Jan; 50(1):255-264. PubMed ID: 28392550
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeted next generation sequencing application in cardiac channelopathies: Analysis of a cohort of autopsy-negative sudden unexplained deaths.
    Farrugia A; Keyser C; Hollard C; Raul JS; Muller J; Ludes B
    Forensic Sci Int; 2015 Sep; 254():5-11. PubMed ID: 26164358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unbiased targeted next-generation sequencing molecular approach for primary immunodeficiency diseases.
    Al-Mousa H; Abouelhoda M; Monies DM; Al-Tassan N; Al-Ghonaium A; Al-Saud B; Al-Dhekri H; Arnaout R; Al-Muhsen S; Ades N; Elshorbagi S; Al Gazlan S; Sheikh F; Dasouki M; El-Baik L; Elamin T; Jaber A; Kheir O; El-Kalioby M; Subhani S; Al Idrissi E; Al-Zahrani M; Alhelale M; Alnader N; Al-Otaibi A; Kattan R; Al Abdelrahman K; Al Breacan MM; Bin Humaid FS; Wakil SM; Alzayer F; Al-Dusery H; Faquih T; Al-Hissi S; Meyer BF; Hawwari A
    J Allergy Clin Immunol; 2016 Jun; 137(6):1780-1787. PubMed ID: 26915675
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a novel LMF1 nonsense mutation responsible for severe hypertriglyceridemia by targeted next-generation sequencing.
    Cefalù AB; Spina R; Noto D; Ingrassia V; Valenti V; Giammanco A; Fayer F; Misiano G; Cocorullo G; Scrimali C; Palesano O; Altieri GI; Ganci A; Barbagallo CM; Averna MR
    J Clin Lipidol; 2017; 11(1):272-281.e8. PubMed ID: 28391895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical validation of a next-generation sequencing screen for mutational hotspots in 46 cancer-related genes.
    Singh RR; Patel KP; Routbort MJ; Reddy NG; Barkoh BA; Handal B; Kanagal-Shamanna R; Greaves WO; Medeiros LJ; Aldape KD; Luthra R
    J Mol Diagn; 2013 Sep; 15(5):607-22. PubMed ID: 23810757
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Next-generation-based targeted sequencing as an efficient tool for the study of the genetic background in Hirschsprung patients.
    Luzón-Toro B; Espino-Paisán L; Fernández RM; Martín-Sánchez M; Antiñolo G; Borrego S
    BMC Med Genet; 2015 Oct; 16():89. PubMed ID: 26437850
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of HaloPlex amplification for sequence capture and massively parallel sequencing of arrhythmogenic right ventricular cardiomyopathy-associated genes.
    Gréen A; Gréen H; Rehnberg M; Svensson A; Gunnarsson C; Jonasson J
    J Mol Diagn; 2015 Jan; 17(1):31-42. PubMed ID: 25445213
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Next-Generation Sequencing Pipeline Outperforms a Combined Approach Using Sanger Sequencing and Multiplex Ligation-Dependent Probe Amplification in Targeted Gene Panel Analysis.
    Schenkel LC; Kerkhof J; Stuart A; Reilly J; Eng B; Woodside C; Levstik A; Howlett CJ; Rupar AC; Knoll JHM; Ainsworth P; Waye JS; Sadikovic B
    J Mol Diagn; 2016 Sep; 18(5):657-667. PubMed ID: 27376475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical utility of a targeted next generation sequencing panel in severe and pediatric onset Mendelian diseases.
    Isik E; Onay H; Atik T; Canda E; Cogulu O; Coker M; Ozkinay F
    Eur J Med Genet; 2019 Oct; 62(10):103725. PubMed ID: 31319225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeted gene panel sequencing in children with very early onset inflammatory bowel disease--evaluation and prospective analysis.
    Kammermeier J; Drury S; James CT; Dziubak R; Ocaka L; Elawad M; Beales P; Lench N; Uhlig HH; Bacchelli C; Shah N
    J Med Genet; 2014 Nov; 51(11):748-55. PubMed ID: 25194001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 85.